Published in Perfusion on March 01, 2002
Re: New guidelines to evaluate the response to treatment in solid tumors (ovarian cancer). J Natl Cancer Inst (2004) 2.79
Chapter 8: Screening for cervical cancer in developing countries. Vaccine (2006) 2.35
Distinct and non-redundant roles of microglia and myeloid subsets in mouse models of Alzheimer's disease. J Neurosci (2011) 2.31
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. Clin Cancer Res (2005) 2.24
Definitions for response and progression in ovarian cancer clinical trials incorporating RECIST 1.1 and CA 125 agreed by the Gynecological Cancer Intergroup (GCIG). Int J Gynecol Cancer (2011) 2.09
Epithelial mesenchymal transition and cancer stem cell-like phenotypes facilitate chemoresistance in recurrent ovarian cancer. Curr Cancer Drug Targets (2010) 1.91
A new prognostic model for FIGO stage 1 epithelial ovarian cancer. Gynecol Oncol (2006) 1.43
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin. Cancer Res (2012) 1.39
Role of integrin receptors for fibronectin, collagen and laminin in the regulation of ovarian carcinoma functions in response to a matrix microenvironment. Clin Exp Metastasis (2005) 1.30
An approach to remove albumin for the proteomic analysis of low abundance biomarkers in human serum. Proteomics (2003) 1.30
Nomogram to predict the probability of relapse in patients diagnosed with borderline ovarian tumors. Int J Gynecol Cancer (2013) 1.25
Cannulation of the axillary artery for cardiopulmonary bypass: safeguards and pitfalls. Ann Thorac Surg (2003) 1.23
Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia. Vaccine (2004) 1.12
Cancerous ovarian stem cells: obscure targets for therapy but relevant to chemoresistance. J Cell Biochem (2013) 1.10
First-line therapy in ovarian cancer trials. Int J Gynecol Cancer (2011) 1.03
Pontocerebellar hypoplasia type 6: A British case with PEHO-like features. Am J Med Genet A (2010) 1.02
Attributes of Oct4 in stem cell biology: perspectives on cancer stem cells of the ovary. J Ovarian Res (2012) 1.02
Microwave tomography of extremities: 2. Functional fused imaging of flow reduction and simulated compartment syndrome. Phys Med Biol (2011) 1.01
The impact of PET/CT in the management of recurrent ovarian cancer. Gynecol Oncol (2006) 1.00
Single coronary artery. J Am Coll Cardiol (2009) 1.00
Microwave tomography of extremities: 1. Dedicated 2D system and physiological signatures. Phys Med Biol (2011) 0.99
Malignant transformation within ovarian dermoid cysts: an audit of treatment received and patient outcomes. an Australia New Zealand gynaecological oncology group (ANZGOG) and gynaecologic cancer intergroup (GCIG) study. Int J Gynecol Cancer (2010) 0.96
Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds. Brain Res Rev (2007) 0.95
Association between alphavbeta6 integrin expression, elevated p42/44 kDa MAPK, and plasminogen-dependent matrix degradation in ovarian cancer. J Cell Biochem (2002) 0.93
Outcome in women with no endocervical component on cervical cytology after treatment for high-grade cervical dysplasia. Aust N Z J Obstet Gynaecol (2009) 0.88
FIGO Cancer Report 2012. Int J Gynaecol Obstet (2012) 0.87
Prognostic value of elevated preoperative serum CA125 in ovarian tumors of low malignant potential: a multinational collaborative study (ANZGOG0801). Gynecol Oncol (2012) 0.87
Anxiety and depression symptoms in the 2 years following diagnosis of breast or gynaecologic cancer: prevalence, course and determinants of outcome. Support Care Cancer (2015) 0.86
Proteomic profiling of proteins associated with urokinase plasminogen activator receptor in a colon cancer cell line using an antisense approach. Proteomics (2003) 0.85
Impaired Th1 immunity in ovarian cancer patients is mediated by TNFR2+ Tregs within the tumor microenvironment. Clin Immunol (2013) 0.84
An investigation into the relationship between vigabatrin, movement disorders, and brain magnetic resonance imaging abnormalities in children with infantile spasms. Dev Med Child Neurol (2013) 0.84
Incidence of microsatellite instability in synchronous tumors of the ovary and endometrium. Clin Cancer Res (2003) 0.84
Gynecologic Cancer InterGroup (GCIG) consensus review for ovarian tumors of low malignant potential (borderline ovarian tumors). Int J Gynecol Cancer (2014) 0.84
Screening for depression and anxiety in women with breast and gynaecologic cancer: course and prevalence of morbidity over 12 months. Psychooncology (2013) 0.83
Current academic clinical trials in ovarian cancer: Gynecologic Cancer Intergroup and US National Cancer Institute Clinical Trials Planning Meeting, May 2009. Int J Gynecol Cancer (2010) 0.83
A phase II trial of capecitabine in heavily pre-treated platinum-resistant ovarian cancer. Gynecol Oncol (2004) 0.83
Complementary medicine use by Australian women with gynaecological cancer. Psychooncology (2006) 0.82
Should the Pap smear be repeated at the first colposcopy visit? Aust N Z J Obstet Gynaecol (2005) 0.82
Persistent trophoblast disease following partial molar pregnancy. Aust N Z J Obstet Gynaecol (2006) 0.82
Re-transplantation after bortezomib-based therapy. Br J Haematol (2011) 0.82
Excessive bleeding and transfusion in a prior cardiac surgery is associated with excessive bleeding and transfusion in the next surgery. Anesth Analg (2006) 0.82
Cotyledonoid dissecting leiomyoma. Pathology (2003) 0.82
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report. Int J Gynecol Cancer (2016) 0.81
Hereditary gynecologic cancers. Int J Gynaecol Obstet (2013) 0.80
Question 1: Should steroids be used to treat abdominal pain caused by Henoch-Schonlein purpura? Arch Dis Child (2012) 0.80
Guidelines following hydatidiform mole: a reappraisal. Aust N Z J Obstet Gynaecol (2006) 0.79
Women with low-grade abnormalities on Pap smear should be referred for colposcopy. Aust N Z J Obstet Gynaecol (2004) 0.78
Should the standard dimethyl sulfoxide concentration be reduced? Results of a European Group for Blood and Marrow Transplantation prospective noninterventional study on usage and side effects of dimethyl sulfoxide. Transfusion (2014) 0.78
Impact of polymethylpentene oxygenators on outcomes of all extracorporeal life support patients in the United States. Artif Organs (2013) 0.78
Findings and Outcomes in a Prevaccination Cohort of Women Younger Than 25 Years Attending a Tertiary Colposcopy Service. J Low Genit Tract Dis (2016) 0.77
Gynecologic Cancer InterGroup (GCIG) Endometrial Cancer Clinical Trials Planning Meeting: taking endometrial cancer trials into the translational era. Int J Gynecol Cancer (2013) 0.77
Substantially modified ratios of effector to regulatory T cells during chemotherapy in ovarian cancer patients return to pre-treatment levels at completion: implications for immunotherapy. Cancers (Basel) (2012) 0.77
Glycosylation of pilin and nonpilin protein constructs by Pseudomonas aeruginosa 1244. J Bacteriol (2010) 0.77
"Like roulette": Australian women's explanations of gynecological cancers. Soc Sci Med (2005) 0.77
Reproductive consequences of EDCs in birds: what do laboratory effects mean in field species? Neurotoxicol Teratol (2002) 0.76
Corrigendum: Whole-genome characterization of chemoresistant ovarian cancer. Nature (2015) 0.75
Risk stratification for free. Br J Gen Pract (2016) 0.75
Variability in CRP, regulatory T cells and effector T cells over time in gynaecological cancer patients: a study of potential oscillatory behaviour and correlations. J Transl Med (2014) 0.75
Partnership for Healthier Asians: Disseminating Evidence-Based Practices in Asian-American Communities Using a Market-Oriented and Multilevel Approach. JMIR Res Protoc (2016) 0.75
The effect of an extended flexor carpi radialis approach on blood flow to the distal radius: a cadaveric study. Orthopedics (2005) 0.75
Uterine Papillary Serous Carcinoma: A Single-Institution Review of 62 Cases. Int J Gynecol Cancer (2016) 0.75
Concussion symptoms in youth motocross riders: a prospective, observational study. J Neurosurg Pediatr (2015) 0.75
The new role of the perfusionist in adult extracorporeal life support. Perfusion (2010) 0.75
Alopecia neoplastica caused by desmoplastic melanoma. Australas J Dermatol (2003) 0.75
Treatment decisions: a qualitative study with women with gynaecological cancer. Aust N Z J Obstet Gynaecol (2006) 0.75
Increased versus stable doses of inhaled corticosteroids for exacerbations of chronic asthma in adults and children. Cochrane Database Syst Rev (2016) 0.75
'He's telling us something'. Anthropol Med (2004) 0.75
Embodied changes and the search for gynecological cancer diagnosis. Med Anthropol Q (2004) 0.75
Is colposcopy needed following laser ablation for dysplasia? Aust N Z J Obstet Gynaecol (2006) 0.75
Challenging Salpingectomy as a Risk-Reducing Measure for Ovarian Cancer: Histopathological Analysis of the Tubo-Ovarian Interface in Women Undergoing Risk-Reducing Salpingo-oophorectomy. Int J Gynecol Cancer (2017) 0.75
Maxillomandibular distraction osteogenesis advancement for the treatment of obstructive sleep apnea. J Oral Maxillofac Surg (2007) 0.75
A comparison of several variables of off-pump coronary artery bypass procedures versus myocardial revascularization utilizing cardiopulmonary bypass. Perfusion (2002) 0.75
Benign endocervical cystic glandular change mimicking minimal deviation adenocarcinoma of the cervix on magnetic resonance imaging: a case report. Aust N Z J Obstet Gynaecol (2004) 0.75